Similar articles

• Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study.

  Bensimhon D, Weintraub WS, Peacock WF, Alexy T, McLean D, Haas D, Deering KL, Millar SJ, Goodwin MM, Mohr JF. Bensimhon D, et al. Future Cardiol. 2023 Jun;19(8):385-396. doi: 10.2217/fca-2023-0071. Epub 2023 Aug 23. Future Cardiol. 2023. PMID: 37609913
• Administration of Subcutaneous Furosemide in Elastomeric Pump vs. Oral Solution for the Treatment of Diuretic Refractory Congestion.

  López-Vilella R, Sánchez-Lázaro I, Husillos Tamarit I, Monte Boquet E, Núñez Villota J, Donoso Trenado V, Martínez Dolz L, Almenar Bonet L. López-Vilella R, et al. High Blood Press Cardiovasc Prev. 2021 Nov;28(6):589-596. doi: 10.1007/s40292-021-00476-4. Epub 2021 Oct 1. High Blood Press Cardiovasc Prev. 2021. PMID: 34596886
• Efficacy and Safety of Subcutaneous Infusion of Non-formulated Furosemide in Patients with Worsening Heart Failure: a Real-World Study.

  Civera J, de la Espriella R, Heredia R, Miñana G, Santas E, Conesa A, Mollar A, Sastre C, Martínez A, Villaescusa A, Núñez J. Civera J, et al. J Cardiovasc Transl Res. 2022 Jun;15(3):644-652. doi: 10.1007/s12265-021-10173-1. Epub 2021 Oct 12. J Cardiovasc Transl Res. 2022. PMID: 34642870 Free PMC article.
• Subcutaneous furosemide for the treatment of heart failure: a state-of-the art review.

  Afari ME, Aoun J, Khare S, Tsao L. Afari ME, et al. Heart Fail Rev. 2019 May;24(3):309-313. doi: 10.1007/s10741-018-9760-6. Heart Fail Rev. 2019. PMID: 30617666 Review.
• Co-Administration of Albumin and Furosemide in Acute Heart Failure with Diuretics Resistance.

  Fernandes J, Costa R, Guerreiro R, Bonifácio D, Rodrigues A, Henriques C, Branco P, Araújo I, Fonseca C. Fernandes J, et al. Acta Med Port. 2023 Mar 1;36(3):193-201. doi: 10.20344/amp.17714. Epub 2023 Feb 10. Acta Med Port. 2023. PMID: 36762993 Review.